Skip to main content

Advertisement

Log in

Modulation of human motor cortex excitability by valproate

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Valproate is widely used in the treatment of epilepsy, bipolar disorder, and chronic pain disorders, but its exact mechanisms of action is still incompletely understood.

Objectives

Here we used transcranial magnetic stimulation to explore effects of a single dose of 800 mg valproate on motor cortex excitability in healthy volunteers.

Methods

Motor threshold, peripheral maximum M-wave, cortical silent period short intracortical inhibition, intracortical facilitation, and motor evoked potential recruitment were assessed before and 1.5 h after the administration of valproate in 15 (eight male, seven female) healthy volunteers.

Results

None of the measures of cortical excitability were found to be altered significantly after valproate.

Conclusion

These results are in line with previous findings of unaffected intracortical excitability after a single dose of valproate, suggesting that valproate’s immediate in vivo actions do not resemble the effects of classic GABAergic compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Faul F, Erdfelder E, Lang A, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Meth 39(2):175–191

    Article  Google Scholar 

  • Johannessen CU (2000) Mechanisms of action of valproate: a commentatory. Neurochem Int 37(2–3):103–110

    Article  PubMed  CAS  Google Scholar 

  • Johannessen CU, Johannessen SI (2003) Valproate: past, present, and future. CNS Drug Rev 9(2):199–216

    Article  PubMed  CAS  Google Scholar 

  • Kapogiannis D, Wassermann EM (2008) Transcranial magnetic stimulation in clinical pharmacology. Cent Nerv Syst Agents Med Chem 8(4):234–240

    PubMed  CAS  Google Scholar 

  • Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A et al (1993) Corticocortical inhibition in human motor cortex. J Phys 471:501–519

    CAS  Google Scholar 

  • Langguth B, Bauer E, Feix S, Landgrebe M, Binder H, Sand P et al (2007) Modulation of human motor cortex excitability by the cholinesterase inhibitor rivastigmine. Neurosci Lett 415(1):40–44

    Article  PubMed  CAS  Google Scholar 

  • Langguth B, Eichhammer P, Spranz C, Landgrebe M, Frick U, Sand P et al (2008) Modulation of human motor cortex excitability by quetiapine. Psychopharmacology 196(4):623–629

    Article  PubMed  CAS  Google Scholar 

  • Li X, Ricci R, Large CH, Anderson B, Nahas Z, George MS et al (2009) Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm 116(4):423–429

    Article  PubMed  CAS  Google Scholar 

  • O’Keefe D (2007) Post hoc power, observed power, a priori power, retrospective power, prospective power, achieved power: sorting out appropriate uses of statistical power analyses. Commun Meth Measures 1(4):291–299

    Article  Google Scholar 

  • Reis J, Tergau F, Hamer HM, Müller H, Knake S, Fritsch B et al (2002) Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 43(10):1149–1156

    Article  PubMed  CAS  Google Scholar 

  • Rho JM, Sankar R (1999) The pharmacologic basis of antiepileptic drug action. Epilepsia 40(11):1471–1483

    Article  PubMed  CAS  Google Scholar 

  • Rizzo V, Quartarone A, Bagnato S, Battaglia F, Majorana G, Girlanda P (2001) Modification of cortical excitability induced by gabapentin: a study by transcranial magnetic stimulation. Neurol Sci 22(3):229–232

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg G (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 64(16):2090–2103

    Article  PubMed  CAS  Google Scholar 

  • Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ et al (1994) Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91(2):79–92

    Article  PubMed  CAS  Google Scholar 

  • Sohn YH, Kaelin-Lang a, Jung HY, Hallett M (2001) Effect of levetiracetam on human corticospinal excitability. Neurology 57(5):858–863

    PubMed  CAS  Google Scholar 

  • Thomas L (1997) Retrospective power analysis. Conserv Biol 11(1):276–280

    Article  Google Scholar 

  • Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J (1999) Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Phys 517(2):591–597

    Article  CAS  Google Scholar 

  • Ziemann U (2004) TMS and drugs. Clin Neurophysiol 115(8):1717–1729

    Article  PubMed  CAS  Google Scholar 

  • Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W (1996) Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 40(3):367–378

    Article  PubMed  CAS  Google Scholar 

  • Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W (1999) Motor excitability changes under antiepileptic drugs. Adv Neurol 81:291–298

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Sandra Pfluegl and Helene Niebling for technical assistance.

Matthias Zunhammer has been supported by the Elite Network Bavaria.

Disclosures

None of the authors has any conflict of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Berthold Langguth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zunhammer, M., Langguth, B., Landgrebe, M. et al. Modulation of human motor cortex excitability by valproate. Psychopharmacology 215, 277–280 (2011). https://doi.org/10.1007/s00213-010-2126-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-010-2126-y

Keywords

Navigation